12 2010
Six-day conference on marine biotechnology held in Italy, June 2010
A six-day conference on marine biotechnology will be held in Acquafredda di Maratea, Italy from 20 to 25 June 2010.
This conference is designed to promote scientific excellence in marine biotechnology, give a platform for leading scientists and young researchers to present their work and discuss the future of the field in Europe. Organised around seven-half day sessions, event topics will include:
- algae and seaweed biomass;
- aquaculture;
- bioprospecting;
- human and environmental health;
- enzymes;
- marine bionanotechnology and biomaterials;
- marine models;
- pollution and bioremediation;
- bioinformatics and research infrastructures
08 2010
National Seminar on Marine Biotechnology- SEMBIOT ‘10, India
National seminar on Marine Biotechnology is being organised by the Centre for Development of Marine Biotechnology, School of Marine Sciences, CUSAT, Cochin, during 25-27 March 2010 at the School of Marine Sciences.
The seminar will cover the latest developments and applications of marine biotechnology and its implications to the management of marine environment.
Topics to include:
- Marine natural products and composite materials
- Bioactive marine natural products
- Drugs from the sea
- Marine natural products, biopolymers and enzymes for industries
- New types of composite materials
31 2010
Scripps researchers win race to synthesize marine natural product Palau’amine
The compound Palau’amine, discovered in 1993, is so chemically complex that finding a way to produce it in the laboratory became the most hotly pursued synthetic chemistry goal in modern history. Groups around the globe dedicated millions to the challenge, but it is a team of scientists from The Scripps Research Institute that has finally completed the quest.
31 2010
GRC hosts Marine Natural Products conference in California, Feb 2010
The mission of the 2010 MNP GRC is to bring traditional participants in this area, including natural products chemists, synthetic chemists and marine biologists, together with specialists in newly emerging areas of marine microbiology, molecular biology, genetic engineering and genomics in a highly interactive forum where new avenues of research will be developed.
Applications for this meeting must be submitted by February 7, 2010.
31 2010
Collaboraton working with deep sea microorganisms for agriculture solutions
Marrone Bio Innovations, Inc. (MBI), is collaborating with the laboratories of research microbiologist Dr. Paul Jensen and Professor William Fenical at the University of California at San Diego, Scripps Institute, to find deep sea microorganisms with potential applications for pest management. UC’s Industry University Cooperative Research Program (IUCRP) awarded Dr. Jensen’s Lab a Discovery Grant for the joint project.
Dr. Jensen’s lab collaborates with the lab of Dr. William Fenical who is internationally recognized for significant discoveries of new pharmaceutical compounds from naturally occurring marine microorganisms. MBI is also developing a novel marine microorganism discovered by Dupont and Biomar, S.A. for use as a rice herbicide.
28 2010
Federal stimulus dollars go to cooperative group targeting discovery of marine-derived anticancer leads
The overall goal of the National Cooperative Drug Discovery Group (NCDDG) program is to discover marine natural product leads for cancer chemotherapy. There are four laboratory programs operating in a close and synergistic fashion as follows:
- Lab Program #1 led by Prof. Phillip Crews (PI of this NCDDG), University of California, Santa Cruz (UCSC)
- Lab Program #2 led by Prof. William Gerwick, Oregon State University (OSU)
- Lab Program #3 led by Dr. Amy Wright, Harbor Branch Oceanographic Institution (HBOI)
- Lab Program #4 led by Prof. William Fenical, Scripps Institution of Oceanography, University of California San Diego (SIO-UCSD).
| Amount of Award: | $273,147 |
| Award Date: | 09/25/2009 |
14 2010
Protective Effects of Squid Ink Extracts
As reported in Marine Drugs, researchers in China recently ran a study in mice to investigate the protective effects of squid ink in chemotherapy.
Although the squid ink extract had little effect on hemopoiesis of marrow in natural mice, elevation of antioxidant ability of the spleen in natural mice was induced by the marine extract, which implied that squid ink may be conducive to improved hemopoietic function of natural mice by improving the function of the spleen.
The data suggest that squid ink extract can protect the hemopoietic system from chemotherapeutic injury and could be employed to develop cell-protective drugs for use in clinical treatment of tumors.
14 2010
GlycoMar files four patents advancing search for new drugs from the sea
GlycoMar Limited announces the filing of four US patent applications, which marks an important step forward for its drug discovery program. Four new composition of matter patent applications have been jointly filed with Verona Pharma plc for products that have been discovered as a result of their collaborative research program. These novel products have been identified from a number of marine organisms and have shown significant anti-inflammatory activity with clinical potential.
The compounds produced by GlycoMar from marine organisms including starfish, sea squirts, and marine worms.
16 2009
China: HUYA Bioscience International forms strategic partnership with Ocean University
HUYA Bioscience International, a leader in globalizing China’s biopharmaceutical innovation, announced recently a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is another in a series of collaborations that HUYA has established with China’s leading research and development institutions to enable and accelerate the global development and commercialization of novel biopharmaceutical product opportunities originating in China.
Ocean University of China, located in Qingdao, is one of the top universities in China. It is considered a leader in research in the area of marine pharmaceutical science, and has received numerous awards for its work.
26 2009
New Issue of Marine Drugs Available
The release of following issue: Mar. Drugs, Volume 7, Issue 3 (September 2009), Pages 268-482 is available at
http://www.mdpi.com/1660-3397/7/3/
Marine Drugs (ISSN 1660-3397, CODEN: MDARE6) is an open access journal on the research, development and production of drugs from the sea, including marine natural product chemistry. Published online quarterly.
RSS Feed 
Search
News Archive
Categories
Sponsors
Latest News
- Unilever and Solazyme to jointly develop oils from algae
- Norwegian Omega-3 oil from Calamari hits the market
- Marine ingredient-based liquid fertilizers promoted for helping plants fight drought in Philippines
- Clay-algal extract combination has use in antibiotec-free animal feed and purification of water from waste effluents
- Marine Ingredient Entrepreneur Talking Up Seaweed and Nova Scotia at the Olympics
Recent Comments
- Kristina on Bodega Algae and Bigelow Lab land SBIR grant
- Research shows effectiveness of natural seaweed extract on … | Health News on Research shows effectiveness of natural seaweed extract on Osteoarthritis symptoms
- Aquapreneur - Research shows effectiveness of natural seaweed … | Health News on Research shows effectiveness of natural seaweed extract on Osteoarthritis symptoms
- Dr Mark G J Hartl on National Seminar on Marine Biotechnology- SEMBIOT ‘10, India
- Ольга on UK’s marine science sector flourishing
Share Aquapreneur
